Literature DB >> 23589056

Minimally invasive aortic valve replacement with orthotopic liver transplantation: report of a case.

Jonathan D Harrison1, Craig H Selzman, Heather F Thiesset, Terry Box, William R Hutson, Jeffrey K Lu, Jeffrey Campsen, John B Sorensen, Robin D Kim.   

Abstract

Cardiac surgery and liver transplantation (LT) are rarely performed at the same time, because of the potential risks of coupling two such complex surgical procedures [1-3]. This combined surgery is typically reserved for patients with structural heart disease, including multivessel obstructive coronary artery disease and severe valvular disease with heart failure and end-stage liver disease, in whom the untreated organ may decompensate if only one organ is addressed [4]. Combined aortic valve replacement (AVR) and LT is the rarest of such combined surgery, with only ten cases published previously. We present the first reported case of combined minimally invasive AVR and LT and review the literature on similar combined surgery.

Entities:  

Mesh:

Year:  2013        PMID: 23589056     DOI: 10.1007/s00595-013-0559-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Combined aortic valve replacement and orthotopic liver transplantation.

Authors:  B M Parker; J T Mayes; J M Henderson; R M Savage
Journal:  J Cardiothorac Vasc Anesth       Date:  2001-08       Impact factor: 2.628

2.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

3.  Early and late outcomes of cardiac surgery in patients with liver cirrhosis.

Authors:  Gonzalo Gonzalez-Stawinski
Journal:  Liver Transpl       Date:  2007-07       Impact factor: 5.799

4.  Minimally invasive approach for aortic valve operations.

Authors:  D M Cosgrove; J F Sabik
Journal:  Ann Thorac Surg       Date:  1996-08       Impact factor: 4.330

5.  Outcomes of simultaneous liver transplantation and elective cardiac surgical procedures.

Authors:  Brian Lima; Edward R Nowicki; Charles M Miller; Koji Hashimoto; Nicholas G Smedira; Gonzalo V Gonzalez-Stawinski
Journal:  Ann Thorac Surg       Date:  2011-09-23       Impact factor: 4.330

Review 6.  Combined cardiac surgery and liver transplantation: three decades of worldwide results.

Authors:  Alexandros Giakoustidis; Thomas P Cherian; Nikolaos Antoniadis; Dimitrios Giakoustidis
Journal:  J Gastrointestin Liver Dis       Date:  2011-12       Impact factor: 2.008

Review 7.  Surgical management of minimally invasive aortic valve operations.

Authors:  William F Johnston; Gorav Ailawadi
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2011-12-22

8.  Donor intracaval thrombus formation and pulmonary embolism after simultaneous piggyback liver transplantation and aortic valve replacement.

Authors:  Seigo Nishida; Anil Vaidya; Edson Franco; Guy Neff; Juan Madariaga; Noboru Nakamura; David M Levi; Jose R Nery; Hooshang Bolooki; Andreas G Tzakis
Journal:  Clin Transplant       Date:  2003-10       Impact factor: 2.863

9.  Early and late outcome of cardiac surgery in patients with liver cirrhosis.

Authors:  Farzan Filsoufi; Sacha P Salzberg; Parwis B Rahmanian; Thomas D Schiano; Hussien Elsiesy; Anthony Squire; David H Adams
Journal:  Liver Transpl       Date:  2007-07       Impact factor: 5.799

10.  Anesthesia for combined cardiac surgery and liver transplant.

Authors:  Christopher C DeStephano; Barry A Harrison; Monica Mordecai; Claudia C Crawford; Timothy S J Shine; Winston R Hewitt; Lawrence R McBride; Michael J Murray
Journal:  J Cardiothorac Vasc Anesth       Date:  2009-12-29       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.